Please assess the completion status of the following clinical trial:

Trial Title: Utility of Pharmacogenomic Testing and Postoperative Dental Pain Outcomes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who are able to read, comprehend, and sign the consent form, and willing to stay in the study unit for up to 12 hours.~* Patients who are reliable, cooperative, and of adequate intelligence to record the requested information on the questionnaire form(s).~* Women of childbearing potential who are not pregnant, as assessed by a urine pregnancy quick test on the day of the procedure, prior to surgery. Women must be using a method of birth control deemed acceptable by the investigator and continue to use this method during the duration of dosing with study medication~* Patient who develop sufficient levels of pain (rated at 50mm or more out of a 100 mm) on the DPIS within 6 hours post-surgical extraction.~* Patients who agree not to take analgesics other than protocol-defined rescue analgesics during the post-operative treatment period of 6 hours.~  * Patients who agree to refrain from alcohol and sedative consumption during the post-operative period of 6 hours.~* Patients scheduled to undergo surgical removal of 3 or more impacted third molars, at least 1 of which must be a bony mandibular impaction. In addition, the sum of the dental impaction scores must be 9 or above, carried out by investigator.~Exclusion Criteria:~Subjects with:~* Known opioids and NSAIDs allergies (or induced asthmatic attacks)~* Known history of opioid abuse~* Recent history of gastrointestinal ulceration~* History of aspirin intolerance/cross-sensitivity~* Recent myocardial disease~* Uncontrolled hypertension~* Patients receiving anticoagulation therapy~* Uncontrolled diabetes~* Pregnant women~* Immunosuppression~* Recent history of opioid or NSAID therapies~* Subjects who do not achieve a qualifying baseline pain threshold of 50mm out of 100mm on the visual analog DIPS within 6 hours of completion of surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- Standard of Care (Type: ACTIVE_COMPARATOR): Individuals within this group will receive standard of care for postoperative dental pain secondary to extraction of impacted mandibular third molar(s)
- Pharmacogenomic Group (Type: EXPERIMENTAL): Individuals within this group will receive pharmacogenomic testing guided prescription of pain medication for postoperative dental pain secondary to extraction of impacted mandibular third molar(s)

Based on this trial design, predict the completion outcome and termination type (if applicable).